PharmaCom BioVet, Inc. (OTCPK: PHMB)
Health Care · Health Care Providers & Services · US
$—
— today · — 1Y
PharmaCom BioVet, Inc. (OTCPK: PHMB) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $10.79K and employs 0 people.
trading between 0.00 and 0.00.
PHMB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.79K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -6.65
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.78B
- Employees
- 0
- Next earnings
- —
About PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV Gold Inc. before officially changing its name to PharmaCom BioVet, Inc. in August 2008. Its corporate base is located in Raleigh, North Carolina.
- ISIN
- US71720A1079
- Founded
- 1995
- Listed since
- May 5, 1999
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $359.94B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $120.63B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $104.54B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.48B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $87.30B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $74.22B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.55B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.45B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.